Takayasu Arteritis

Introducing Our 2022-2023 VCRC-VF Fellow: Gözde Kübra Yardimci, MD

Gözde Kübra Yardimci, MD, began her one-year Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship in July 2022 at Mount Sinai Hospital, University of Toronto, Ontario, Canada. Her main areas of interest at present are severe ischemic events in Takayasu arteritis and Behçet’s syndrome. Through her fellowship, Dr. Yardimci is…...

Read more

University of Michigan’s Vasculitis Program: Hoping to Impact Individual Patients and the Approach to the Diseases

Julia Ford, MD (left) and Ora Singer, MD, MS  The University of Michigan (U-M) Vasculitis Program began in September 2021 with a soft launch. “We started simply by instituting a dedicated vasculitis clinic and have been moving forward step by step,” said Ora Singer, MD, MS, Director of U-M’s Vasculitis…...

Read more

Pitt Scientists Identify Genetic Risks of Rare Inflammatory Disease

PITTSBURGH, Dec. 11, 2020 – In a paper published today in the American Journal of Human Genetics, a group of international collaborators led by researchers from the University of Pittsburgh School of Medicine identified new genetic associations that can predict individual susceptibility to a rare inflammatory disease called Takayasu arteritis.…...

Read more

Positivity, Perseverance Inspires Other Young Adults in Vasculitis Community

This summer’s International Vasculitis Symposium in Bloomington, Minnesota, marked another successful gathering of young adults and continued the growth of our community. While it was great to see old friends again, I was reminded of how this disease continues to impact new people every year, and how scary and daunting…...

Read more